• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性黄斑水肿激光光凝术后的视网膜下纤维化

Subretinal fibrosis after laser photocoagulation for diabetic macular edema.

作者信息

Guyer D R, D'Amico D J, Smith C W

机构信息

Retina Service, Massachusetts Eye and Ear Infirmary, Boston 02114.

出版信息

Am J Ophthalmol. 1992 Jun 15;113(6):652-6. doi: 10.1016/s0002-9394(14)74789-0.

DOI:10.1016/s0002-9394(14)74789-0
PMID:1376019
Abstract

Seven eyes had subretinal fibrosis after grid laser photocoagulation for diabetic macular edema. The fibrosis caused persistent loss in visual acuity, and in six of the seven eyes, was not associated with detectable laser-induced Bruch's membrane rupture or subretinal hemorrhage. Choroidal neovascularization was detected in only one patient, who was notably younger (27 years) than the median age of 70 years in this series. The median preoperative visual acuity was 20/80 (range, 20/40 to 20/400); the median postoperative visual acuity was 20/400 (range, 20/80 to counting fingers). The subretinal fibrosis was detected at a median of three months (range, 14 days to 4 1/2 months) after laser therapy. In one of five bilaterally treated patients (20%), subretinal fibrosis developed in both eyes. Subretinal fibrosis may be caused by undetected choroidal neovascularization or by excessive proliferation after stimulation of an aged retinal pigment epithelium. Subretinal fibrosis may be a potential cause of loss in visual acuity after laser treatment for diabetic macular edema.

摘要

7只眼睛在接受格栅样激光光凝治疗糖尿病性黄斑水肿后出现了视网膜下纤维化。这种纤维化导致视力持续丧失,在这7只眼睛中的6只中,与可检测到的激光诱导的 Bruch 膜破裂或视网膜下出血无关。仅1例患者检测到脉络膜新生血管,该患者明显比本系列患者的中位年龄70岁年轻(27岁)。术前视力中位数为20/80(范围为20/40至20/400);术后视力中位数为20/400(范围为20/80至数指)。视网膜下纤维化在激光治疗后中位数3个月(范围为14天至4个半月)被检测到。在5例双侧治疗的患者中,有1例(20%)双眼均出现视网膜下纤维化。视网膜下纤维化可能由未检测到的脉络膜新生血管或老年视网膜色素上皮受到刺激后的过度增殖引起。视网膜下纤维化可能是糖尿病性黄斑水肿激光治疗后视力丧失的一个潜在原因。

相似文献

1
Subretinal fibrosis after laser photocoagulation for diabetic macular edema.糖尿病性黄斑水肿激光光凝术后的视网膜下纤维化
Am J Ophthalmol. 1992 Jun 15;113(6):652-6. doi: 10.1016/s0002-9394(14)74789-0.
2
Submacular fibrosis after photocoagulation for diabetic macular edema.糖尿病性黄斑水肿光凝治疗后的黄斑下纤维化
Am J Ophthalmol. 1992 May 15;113(5):513-21. doi: 10.1016/s0002-9394(14)74722-1.
3
Subretinal neovascularization after focal argon laser for diabetic macular edema.糖尿病性黄斑水肿局部氩激光治疗后视网膜下新生血管形成
Ophthalmology. 1988 May;95(5):567-73. doi: 10.1016/s0161-6420(88)33148-9.
4
Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema.
Arch Ophthalmol. 1991 Nov;109(11):1549-51. doi: 10.1001/archopht.1991.01080110085041.
5
Iatrogenic choroidal neovascularization after krypton red laser photocoagulation.氪红激光光凝术后医源性脉络膜新生血管形成
Ophthalmic Surg. 1989 Apr;20(4):273-7.
6
Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group.糖尿病性黄斑水肿中的视网膜下纤维化。ETDRS报告23。早期治疗糖尿病性视网膜病变研究组。
Arch Ophthalmol. 1997 Jul;115(7):873-7. doi: 10.1001/archopht.1997.01100160043006.
7
Choroidal neovascularization after laser photocoagulation for diabetic macular edema.
Ophthalmology. 1990 Apr;97(4):503-10; discussion 510-1. doi: 10.1016/s0161-6420(90)32574-5.
8
Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy.
Ophthalmic Surg. 1988 Oct;19(10):734-7.
9
The effect on the macular function of laser photocoagulation for diabetic macular edema.
Graefes Arch Clin Exp Ophthalmol. 1992;230(2):162-5. doi: 10.1007/BF00164656.
10
Choroidal neovascularization in an eye with a macular hole.
Ann Ophthalmol. 1989 Sep;21(9):331-2, 336.

引用本文的文献

1
532 nm versus 810 nm subthreshold micropulse laser in treatment of non-resolving central serous chorioretinopathy: A randomized controlled trial.532纳米与810纳米阈下微脉冲激光治疗不愈性中心性浆液性脉络膜视网膜病变的随机对照试验
Med J Armed Forces India. 2024 Sep-Oct;80(5):535-540. doi: 10.1016/j.mjafi.2022.12.011. Epub 2023 Feb 3.
2
Optimizing Diabetic Macular Edema Treatment: A Meta-Analysis of Subthreshold Micropulse Laser and Anti-Vascular Endothelial Growth Factor Combination Therapy.优化糖尿病性黄斑水肿治疗:阈下微脉冲激光与抗血管内皮生长因子联合治疗的Meta分析
J Clin Med. 2024 Aug 14;13(16):4782. doi: 10.3390/jcm13164782.
3
A Two-Decade Bibliometric Analysis of Laser in Ophthalmology: From Past to Present.
眼科激光领域二十年文献计量分析:从过去到现在
Clin Ophthalmol. 2024 May 13;18:1313-1328. doi: 10.2147/OPTH.S458840. eCollection 2024.
4
A review on photo-mediated ultrasound therapy.光介导超声治疗的综述。
Exp Biol Med (Maywood). 2023 May;248(9):775-786. doi: 10.1177/15353702231181191. Epub 2023 Jul 15.
5
Current Treatments for Diabetic Macular Edema.糖尿病性黄斑水肿的当前治疗方法。
Int J Mol Sci. 2023 May 31;24(11):9591. doi: 10.3390/ijms24119591.
6
Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature.黄色阈下微脉冲激光治疗视网膜疾病:文献的深入分析与综述
Ophthalmol Ther. 2023 Jun;12(3):1479-1500. doi: 10.1007/s40123-023-00698-w. Epub 2023 Mar 18.
7
Conventional and Pattern Scanning Pan-Retinal Photocoagulation Laser in Diabetic Patients' Visual Field.传统与模式扫描全视网膜光凝激光对糖尿病患者视野的影响
J Lasers Med Sci. 2022 Sep 26;13:e40. doi: 10.34172/jlms.2022.40. eCollection 2022.
8
Efficacy of subthreshold micropulse laser combined with ranibizumab in the treatment of diabetic macular edema.亚阈值微脉冲激光联合雷珠单抗治疗糖尿病黄斑水肿的疗效。
Int Ophthalmol. 2022 Dec;42(12):3829-3836. doi: 10.1007/s10792-022-02403-5. Epub 2022 Jul 25.
9
Immune Cells in Subretinal Wound Healing and Fibrosis.视网膜下伤口愈合与纤维化中的免疫细胞
Front Cell Neurosci. 2022 Jun 10;16:916719. doi: 10.3389/fncel.2022.916719. eCollection 2022.
10
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema.比较玻璃体内注射阿柏西普联合亚阈值激光与玻璃体内注射阿柏西普单药治疗糖尿病性黄斑水肿的随机临床试验。
Sci Rep. 2022 Jun 23;12(1):10672. doi: 10.1038/s41598-022-14444-y.